Gaithersburg, Maryland-based Novavax has struck a deal to sell as many as 200 million doses of its still-unapproved COVID-19 vaccine to the European Commission for an undisclosed sum. The agreement covers the purchase of up to 100 million doses of …
See Original Article

In late trading Tuesday, Lyft shares rallied after the ride-sharing company disclosed that it reached profitability one quarter sooner than expected—as measured by adjusted Ebitda, or earnings before interest, taxes, depreciation, and amortization.
See Original Article

Check out what’s clicking on FoxBusiness.com. Global pharmaceutical company BeyondSpring announced positive findings in a late-stage trial of a drug combo to treat second- and third-line nonsmall …
See Original Article

Novo Nordisk’s GLP-1 empire is on the ascent, courtesy of its diabetes stalwarts Ozempic and Rybelsus, plus its newly-approved obesity drug Wegovy. With momentum building—and facing “substantial” demand for its new weight loss med—the Danish …
See Original Article

“This is the most significant rule making in [National Highway Traffic Safety Administration] NHTSA’s history,” Stephanie Manning, government affairs officer for Mothers Against Drunk Driving, said in a statement. “Every year we wait, thousands of people will die.”.
See Original Article